15 research outputs found

    Desenvolvimento e procedimentos de validação de uma metodologia analítica por GC/MS/MS para a determinação de antidepressivos em sangue total

    Get PDF
    A depressão é uma das doenças de foro psiquiátrico que mais prevalece na nossa sociedade, subsistindo evidências epidemiológicas que indicam um aumento substancial da sua incidência nos últimos anos. Esta evidência é consubstanciada pelo aumento significativo do consumo de antidepressivos em Portugal. Este cenário pressupõe a necessidade de uma metodologia que permita analisar, com rigor e numa perspectiva de rotina, os antidepressivos que podem ser encontrados em amostras de sangue. No contexto do Serviço de Toxicologia Forense do Instituto Nacional de Medicina Legal, Delegação do Norte, torna-se necessário o desenvolvimento de uma metodologia analítica para a determinação simultânea de 15 antidepressivos em sangue total e a sua validação relativamente a vários parâmetros analíticos. Os antidepressivos considerados foram Amitriptilina, Citalopram, Clomipramina, N-Desmetilclomipramina, Dotiepina, Fluoxetina, Imipramina, Maprotilina, Mianserina, Mirtazapina, Nortriptilina, Paroxetina, Sertralina, Trimipramina e Venlafaxina. A técnica utilizada para este efeito foi o GC/MS/MS, aplicando um procedimento extractivo prévio apropriado, baseado em procedimentos convencionais de extracção em fase sólida. A escolha desta técnica teve por base a possibilidade de identificar inequivocamente os compostos presentes na amostra, independentemente da complexidade da matriz, e de originar metodologias com uma sensibilidade elevada e com limites de detecção muito baixos. Os parâmetros analíticos considerados para validação da metodologia estabelecida foram selectividade/especificidade e capacidade de identificação; limites de detecção e de quantificação; linearidade e gama de trabalho; eficiência de extracção; arrastamento; exactidão (precisão, veracidade e incerteza de medição) e robustez. Com excepção da exactidão, um parâmetro que carece ainda de estudos complementares, todos os parâmetros estudados foram validados de acordo com os requisitos internos do Serviço. De uma forma geral, os resultados obtidos com o método desenvolvido revelaram-se selectivos e apresentaram respostas analíticas tanto para concentrações de antidepressivos em níveis terapêuticos como para níveis letais destas drogas. Os procedimentos extractivos revelaram-se eficazes e não foram verificados fenómenos de arrastamento em concentrações mais elevadas. O método foi ainda considerado robusto.Depression is one of the most prevalent psychiatric disorders in our society. Solid epidemiological evidence suggests a substantial incidence of the disease in recent years. This is supported by a significant increase in the consumption of antidepressant drugs, creating the need of suitable methods for their accurate analysis in blood samples, carried out in a routine fashion. Focusing the needs of the Serviço de Toxicologia Forense do Instituto Nacional de Medicina Legal, Delegação do Norte, it is important to develop an analytical methodology for the simultaneous determination of 15 antidepressant drugs in whole blood and to validate it with regard to several analytical parameters. The selected antidepressants are Amitriptyline, Citalopram, Clomipramine, N-Desmethylclomipramine, Dothiepin, Fluoxetine, Imipramine, Maprotiline, Mianserine, Mirtazapine, Nortriptyline, Paroxetine, Sertraline, Trimipramine e Venlafaxine. GC/MS/MS was selected for this purpose, after carrying out suitable pre-treating solid-phase extraction procedures. This selection was grounded on the fact that the identification of every compound is ensured and the resulting method offers high sensitivity with low limits of detection. The analytical parameters required for validation included selectivity/specificity and identification capability; limits of detection and quantification; linearity and working concentration range; extraction efficiency; carryover; accuracy (precision, trueness and uncertainty); and robustness. Excluding accuracy that still needs additional testing, all parameters were validated according to the requisites of the Serviço de Toxicologia Forense do Instituto Nacional de Medicina Legal, Delegação do Norte. In general, the obtained results offered good selectivity and analytical responses for the typical concentration ranges of therapeutic and lethal levels. The extraction procedures were effective and no carryover was observed for the highest concentrations. The overall method was found robust

    The potential of molecular imprinting as a biosensing devices for monitoring the CEA cancer biomarker

    Get PDF
    6th Graduate Student Symposium on Molecular Imprinting6th Graduate Student Symposium on Molecular Imprinting, in Medway School of Pharmacy, Kent, UK, August 27-28, 2015Colorectal cancer is the third most common type of cancer and the major cause of the death throughout the world. Widely known, carcinoembryonic antigen (CEA) is an important tumour marker responsible for clinical diagnosis of 95% of all colon tumors1. The discovery of novel non-invasive biomarkers, as CEA, and its fast determination at low cost is presently required, to enable its use over wide screening programs and applications in point-of-care context, and, thus, its monitoring quite early. As a novel approach, this work proposes a novel support with molecular imprinted polymer (MIP) for CEA cancer biomarker based on carbon ink matrix linked by sol-gel chemistry on top of conductive glass covered by fluorine-doped tin oxide (FTO glass). In brief, the electrical biosensor was tailored on top of a disposable conductive glass electrode, following a bottom-up approach. The several stages of this process included the chemical modification of a homemade carbon ink layer and the assembly of a MIP or non-imprinted polymer (NIP) layer. The analytical performance of the obtained devices was followed by electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). Chemical modifications of the surface were characterized using Fourier Transform Infrared (FTIR), and Raman spectroscopy with confocal microscopy. Overall, the MIP/FTO glass-based device displayed linear responses to CEA in EIS assays from 2.5×10-3 µg.mL-1 to 1.25 µg.mL-1 in PBS buffer, with detection limits of 2.5×10-3 µg.mL-1. Successful detection of CEA was, also, achieved in spiked samples of fetal bovine serum. In conclusion, the devices developed are a promising tool for the monitoring of CEA in a point-of-care applications, due to its detection capability below the normal physiological levels expected for this cancer biomarker, simplicity of manufacture, low-cost and good sensitivity and selectivity

    A disposable glass-based immunosensor for monitoring the cancer biomarker CEA in urine

    Get PDF
    NanoPT 2014 International Conference, in Portugal, on February 12-14. Poster presentation based on topic Nanobio/NanomedicineImmunosensing is a fast and cost-effective method in clinical diagnosis, relying on antibody-antigen interaction for the quantitative detection a specific antigen. Different types of antigen species have been screened in this context, including tumor markers, assessed by enzyme-linked immunosorbent, chemiluminescence and electrochemical methods1. Tumor markers are biomolecules in tumor cells or body fluids that may be associated with cancer diseases. Carcinoembryonic antigen (CEA) is among such markers, being employed in clinical diagnosis of over 80% colorectal cancers, with relatively little expression in normal mucosa2,3. Fast determination of CEA at low cost is presently required, to enable its use over wide screening programs and application in point-of-care context. This work presents a new simple immunoassay method for CEA detection in urine using a disposable glass-based immunosensor coupled to electrochemical detection. Conductive glass covered by fluorine doped tin oxide (FTO) was used as conductive support and modified with anti-CEA by means of bottom-up approach. All stages involved in the biochemical modification were followed by electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). The analytical performance of the device was fully characterized by EIS, proving sensitive readings of CEA from 2.5x10-3 to 0.10 ng/mL. The immunosensor was applied to real urine analysis from healthy individual spiked with the antigen. Overall, the combination of the sensory material with electrode design has lead to a promising tool for point-of-care applications, when applied to field monitoring of CEA in urine samples

    Sol-gel biomimetic material designed to target CEA cancer biomarker

    Get PDF
    1st ASPIC International CongressPoster J3, presented at 1st ASPIC International Congress, in Fundação Calouste Gulbenkian, Lisbon, Portugal, November 25-26, 2014.Introduction Carcinoembryonic antigen (CEA) is an important tumor marker responsible for clinical diagnosis of over 95% of all colon tumors, 50% of breast tumors, as well as tumors of the lung cancer or ovarian carcinoma [1]. The detection of CEA levels in biological samples plays an important role in the pre-diagnosis evaluation and in the follow-up examination during therapy stage [2]. The most common tool for the analysis of CEA in hospitals and clinical laboratories relies on ELISA-based procedures using antibodies as capturing probe. The overall principal offers the selectivity and sensitivity out coming from the use of antibodies, but it could be further improved by assembling the biosensors over a receptor platform and establishing a label-free measure by electrical impedance spectroscopy (EIS). Thus, the present work proposes the development of an immunosensor for CEA. Materials and Methods Electrochemical signals were measured in a Methrom Autolab potentiostat/galvanostat (Autolab PGSTAT302N) interfaced to a computer and controlled by NOVA 1.9 software. The chemical modification of the surface of the conductive glass was characterized by Raman spectroscopy with confocal microscopy (Thermo Scientific). The immunosensor was assembled by modifying conductive glass (with ITO) with an amino silane compound (APTES), activating the antibody via carbodiimide chemistry (EDAC/NHS) and binding the antibody to the amine surface over the ITO glass. The performance of the imunosensor was evaluated by electrochemical techniques, namely electrochemical impedance spectroscopy (EIS) and square wave voltammetry (SVW). Results and discussion The immunosensor made with an optimized composition displayed linear behavior against CEA concentration by EIS and SWV techniques. The corresponding linear ranges were 0.502-1.5 and 0.252-1.5ng/mL, with detection limits of 0.417 and 0.043 ng/mL, respectively. Overall, the obtained device may be potential method to apply for screening CEA in point-of-care due to the simplicity of fabrication, short time response, low cost and good sensitivity when compared to other analytical techniques, such as ELISA assays

    Artificial antibodies based potentiometric sensors for monitoring diabetic ketoacidosis

    Get PDF
    Diabetic ketoacidosis is a pathological condition characterized for the complex disordered metabolic state (as hyperglycemia, metabolic acidosis, dehydration or ketosis), caused by the total failing of insulin production for beta cells in the islets of Langerhans (type 1 diabetes) or abnormalities in the peripheral insulin action and insulin secretion (type 2 diabetes). This pathogenesis can be also associated with the increase of counter-regulation hormones, leading to an increase in the hepatic glucose synthesis and a decrease in the peripheral tissues, resulting in hyperglycemia and hyperosmolarity. The effect of lipolysis increase leads to an increase in the production of free fatty acids, which are oxidized in the hepatic microsomal system and converted to acetyl-CoA. When acetyl-CoA production exceeds hepatic utilization capacity, this substance acts as a substrate for the production of ketone bodies (β-hydroxybutyrate (BHB), acetoacetate and acetone), causing ketonemia and metabolic acidosis.info:eu-repo/semantics/publishedVersio

    Coupling gold nanoparticles to Dye-Sensitized Solar Cells for an increased efficiency

    Get PDF
    New approaches for coupling Au NPs to the photoanode of dye sensitized solar cells (DSSCs) were proposed herein, aiming to improve the typical energy conversion efficiency of these cells. For this purpose, colloidal Au NPs with different particles sizes, ∼5 nm and ∼22 nm, were chemically synthesized and attached (i) directly to titanium dioxide (TiO2) or (ii) to TiO2 surface modified with siliceous shells enriched in dithiocarbamate moieties (SiO2/SiDTC). Photoanodes composed by films of TiO2 anatase, TiO2@Au NPs (∼5 nm and ∼22 nm), or TiO2 functionalized with SiO2/SiDTC, loaded with colloidal Au NPs, were made. DSSCs were set-up in a typical sandwich configuration, using the photoanode, a Pt counter electrode, and an iodide electrolyte solution (I−/I3−). In general, a relevant contribution in the plasmonic DSSC performance was evidenced by using Au NPs of ∼22 nm loaded in different amounts 23.9 wt%, 31.0 wt% and 44.0 wt%. Photoanodes composed by 23.9% of Au yielded an increment of 14.40% in photocurrent and of 11.21% in the overall power conversion efficiency (PCE), when compared to the conventional one. In turn, the new strategy used in the chemical modification of the conventional photoanodes with dithiocarbamate groups showed also a significant improvement of the DSSC parameters.publishe

    Carnitine tailored Sensors on Surface Molecular Imprinting based on Graphene layers

    Get PDF
    III Jornadas de Electroquímica e Inovação (Electroquímica e Nanomateriais), na Universidade de Trás-os-Montes e Alto Douro, Vila Real, 16 a 17 de Setembro de 2013III Jornadas de Electroquímica e Inovação (Electroquímica e Nanomateriais), na Universidade de Trás-os-Montes e Alto Douro, Vila Real, 16 a 17 de Setembro de 2013A new biosensor based on surface molecularly imprinted polymer (MIP) on graphene layers was successfully developed. It consists in a 3D polymeric network created on top of surface and around the target template, Carnitine (CRT), a potential biomarker of ovary cancer. The polymeric structure was obtained after radical polymerization of (vinylbenzyl)trimethylammonium chloride, 4-styrenesulfonic acid and vinyl pivalate, including in the reaction mixture ethylene glycol dimethacrylate as cross-linker and ammonium persulphate as initiator. Non-imprinted polymer (NIP) material was also produced, by excluding the template from the procedure. The imprinted graphene structures were further used for the selective determination of CRT by potentiometric transduction. For this purpose, a selective membrane was prepared by using the MIP material as ionophore, and dispersing it in a plasticized poly(vinylchloride) matrix, that included (or not) a suitable amount of charged lipophilic additive. The membranes were casted over a solid conductive support, made of graphite or of conductive glass. Control membranes were also produced by replacing MIP by NIP material. The potentiometric performance of the above electrodes was assessed against CRT solutions of increasing concentrations. Graphite supports displayed the best analytical features, with average slope and detection limit of 40.51 mVdecade-1 and 3.55x10-6 molL-1, respectively. The effect of pH upon the potentiometric response was evaluated for different buffer solutions (within 2-9) and the best performance for this sensor was obtained with HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer of pH 5.2. The interference effect of albumin, ascorbic acid, glucose, creatinine and urea in the performance of the electrochemical unit was tested for concentrations up to their normal physiologic levels in urine and good selectivity was observed. The application of the devices to the analysis of spiked samples showed recoveries ranging from 91% (± 6.8%) to 118% (± 11.2%), with relative errors below -20%. Overall, the combination of the MIP sensory material with a suitable selective membrane and electrode design showed to be a promising tool for point-of-care applications

    A new biomimetic sensor for detecting carnitine, a potential biomarker in ovarian cancer

    Get PDF
    1st ASPIC International Congress1st ASPIC International Congress, Fundação Calouste Gulbenkian, Lisboa, 25-26 de Novembro, 2014Carnitine (CRT) displays an important role in cellular metabolism and energy production. It has actions that include the metabolites associated with glycolysis and β-oxidation of fatty acids. The change of its levels in biological fluids has been associated to the presence of ovarian cancer, making CRT a potential biomarker of the disease. Sensitive CRT determination (in low levels) becomes therefore important, for which a low cost and sensitive device would be appreciated. A biomimetic polymer is proposed herein for this purpose, produced by bulk electropolymerization around a hydrophobic paper substrate that was made conductive by casting a graphite-based ink. Materials and methods The electrode substrate was prepared by modifying cellulose paper, first with solid wax and after with carbon ink. The hydrophobicity of the paper was tested by contact angle and the ink properties evaluated by Thermogravimetry, Raman Spectroscopy and FTIR. Two different biomimetic materials were electropolymerized over the carbon conductive support: 3,4-ethylenedioxythiophene (EDOT) and dodecilbenzenesulfonic acid sodium salt (NaDBS). The polymeric film depositions were obtained by chronoamperometry at 0.9 V vs Ag/AgCl during 240 s. The obtained sensors were characterized by Electrochemical Impedance Spectroscopy (EIS), in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer at pH 7.0

    Host-Tailored Sensors for Carnitine Potentiometric Measurements based on Surface Molecular Imprinting

    Get PDF
    Graduate Student Symposium on Molecular Imprinting 2013, na Queen’s University, Belfast, United Kingdom, 15 a 17 de Agosto de 2013A novel surface molecularly imprinted polymer (MIP) is presented for Carnitine (CRT), a potential biomarker of ovary cancer. It consists in a 3D polymeric network created on top of graphene layers and around the target template. The polymeric structure was obtained after radical polymerization of (vinylbenzyl)trimethylammonium chloride, 4-styrenesulfonic acid and vinyl pivalate, including in the reaction mixture ethylene glycol dimethacrylate as cross-linker and ammonium persulphate as initiator. Non-imprinted polymer (NIP) material was also produced, by excluding the template from the procedure. The imprinted material was further used for the selective determination of CRT by potentiometric transduction. A selective membrane was prepared for this purpose by using the MIP material as ionophore, and dispersing it in a plasticized poly(vinylchloride) matrix with a suitable charged lipophilic additive. All membranes were casted over a solid conductive support made of graphite and applied over the smaller end of an insulin syringe. The best membranes were also applied over conductive glass/plastic. Control membranes were also produced by replacing MIP by NIP material. The potentiometric performance of the above electrodes was evaluated against CRT solutions of increasing concentrations. Overall, the best devices displayed linear response with average slope and detection limit of 47.28 mV.decade-1 and 3.55x10-6 mol.L-1, respectively. The effect of pH upon the potentiometric response was evaluated for different buffer solutions (within 2-9) and the best performance for this sensor was obtained with HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer of pH 5.2. Good selectivity was observed against albumin, ascorbic acid, glucose, creatinine and urea, tested for concentrations up to their normal physiologic levels in urine. The application of the devices to the analysis of spiked samples showed recoveries ranging from 91% (± 6.8%) to 118% (± 11.2%), with relative errors below -20%. Overall, the combination of the MIP sensory material with a suitable selective membrane and electrode design has lead to a promising tool for point-of-care applications, when applied to field monitoring of CRT in biological samples

    Novel optical PVC probes for on-site detection/determination of fluoroquinolones in a solid/liquid interface: Application to the determination of Norfloxacin in aquaculture water

    Get PDF
    A novel optical disposable probe for screening fluoroquinolones in fish farming waters is presented, having Norfloxacin (NFX) as target compound. The colorimetric reaction takes place in the solid/liquid interface consisting of a plasticized PVC layer carrying the colorimetric reagent and the sample solution. NFX solutions dropped on top of this solid-sensory surface provided a colour change from light yellow to dark orange. Several metals were tested as colorimetric reagents and Fe(III) was selected. The main parameters affecting the obtained colour were assessed and optimised in both liquid and solid phases. The corresponding studies were conducted by visible spectrophotometry and digital image acquisition. The three coordinates of the HSL model system of the collected image (Hue, Saturation and Lightness) were obtained by simple image management (enabled in any computer). The analytical response of the optimised solid-state optical probe against concentration was tested for several mathematical transformations of the colour coordinates. Linear behaviour was observed for logarithm NFX concentration against Hue+Lightness. Under this condition, the sensor exhibited a limit of detection below 50 μM (corresponding to about 16 mg/mL). Visual inspection also enabled semi-quantitative information. The selectivity was ensured against drugs from other chemical groups than fluoroquinolones. Finally, similar procedure was used to prepare an array of sensors for NFX, consisting on different metal species. Cu(II), Mn(II) and aluminon were selected for this purpose. The sensor array was used to detect NFX in aquaculture water, without any prior sample manipulation
    corecore